Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity ...

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...

More information Improve your comfort level and enhance your performance with stylish and quality athletic shoes, leggings, shorts, jackets, hats and sunglasses at up to 50% off in Under Armour ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

There's no doubt that 2024 has been the year of semaglutide. In the space of just a few months, the drug - designed originally to treat type 2 diabetes and sold under a variety of brand names ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

A flagship-grade 2000 nits AMOLED display with HDR10+ and a smooth 120Hz refresh rate at an affordable price. The Realme Narzo 70 Pro is ideal for users who prioritize a premium display experience ...

Tombot, a robotic dog for people who can not have a real pet, gets a scratch during 2025 CES Unveiled, Sunday, Jan. 5, 2025, in Las Vegas. (AP Photo/Jack Dempsey) ...